热门资讯> 正文

阿卡迪亚制药将取代独立银行集团成为标准普尔SmallCapital 600指数

2024-12-31 15:35

Acadia Pharmaceuticals (NASDAQ:ACAD) will replace Independent Bank Group (NASDAQ:IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025.
S&P MidCap 400 constituent SouthState (SSB) is acquiring Independent Bank Group (IBTX) in a deal expected to close soon pending final conditions.

More on Acadia Pharma

Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET
Acadia Pharmaceuticals: Proving The Naysayers Wrong
Acadia closes on $150M FDA voucher sale
Acadia signs licensing deal for essential tremor drug candidate

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。